Elanco Animal Health (ELAN) Return on Invested Capital (2019 - 2026)
Elanco Animal Health (ELAN) posted Return on Invested Capital of 0.03% for Q1 2026, up 14.5% sequentially from 0.03% in Q4 2025, and up 4.0% YoY from 0.03% in Q1 2025.
Elanco Animal Health (ELAN) Return on Invested Capital (2019 - 2026) Analysis & Trends
Elanco Animal Health has reported Return on Invested Capital for 8 years, with the latest figure at 0.03% in Q1 2026.
- Quarterly Return on Invested Capital rose 4.0% year-over-year to 0.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03% (up 4.0% YoY) and the FY2025 annual result came in at 0.1%, up 35.0% from the prior year.
- Return on Invested Capital rose to 0.03% in Q1 2026 per ELAN's latest filing, from 0.03% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.03% in Q1 2026 and troughed at 0.14% in Q2 2024.
- A 5-year average of 0.03% and a median of 0.02% in 2024 frame the typical range for Return on Invested Capital.
- The sharpest annual moves came in 2024 and 2025: Return on Invested Capital decreased 12 bps in 2024, then increased 14 bps in 2025.
- Over 5 years, Return on Invested Capital stood at 0.03% in 2022, then slumped by 90 bps to 0.05% in 2023, then jumped by 35 bps to 0.03% in 2024, then soared by 182 bps to 0.03% in 2025, then grew by 15 bps to 0.03% in 2026.
- According to Business Quant data, Return on Invested Capital over the past three periods registered 0.03%, 0.03%, and 0.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.03% |
| Mar 31, 2026 | 0.03% |
| Dec 31, 2025 | 0.03% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -0.02% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.14% |
| Mar 31, 2024 | -0.10% |
| Dec 31, 2023 | -0.05% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.04% |
| Jun 30, 2022 | -0.03% |
| Mar 31, 2022 | -0.02% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.02% |